Chengzhi Co., Ltd. (SHE:000990)
China · Delayed Price · Currency is CNY 11.35
-0.29 (-2.49%)
May 12, 2026, 3:04 PM CST
Chengzhi Market Cap
Chengzhi has a market cap or net worth of 14.15 billion as of May 12, 2026. Its market cap has increased by 64.41% in one year.
Market Cap
14.15B
Enterprise Value
17.98B
Revenue
10.87B
Ranking
n/a
PE Ratio
199.98
Stock Price
11.35
Market Cap Chart
Since January 2, 2001, Chengzhi's market cap has increased from 4.51B to 14.15B, an increase of 213.90%. That is a compound annual growth rate of 4.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 14.15B | 46.97% |
| Dec 31, 2025 | 9.62B | 2.19% |
| Dec 31, 2024 | 9.42B | -5.60% |
| Dec 29, 2023 | 9.98B | -6.70% |
| Dec 30, 2022 | 10.69B | -44.37% |
| Dec 31, 2021 | 19.23B | 33.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jinyu Bio-technology | 16.49B |
| Mabwell (Shanghai) Bioscience | 15.10B |
| Inner Mongolia Furui Medical Science | 14.83B |
| Anhui Anke Biotechnology (Group) | 14.77B |
| Chengdu Olymvax Biopharmaceuticals | 14.22B |
| Staidson (Beijing) BioPharmaceuticals | 13.34B |
| Tibet Cheezheng Tibetan Medicine | 13.04B |
| InventisBio | 12.80B |